Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.17
+0.06005.41%
Post-market: 1.15-0.0200-1.71%19:30 EDT
Volume:170.74K
Turnover:196.09K
Market Cap:17.71M
PE:-1.58
High:1.21
Open:1.12
Low:1.10
Close:1.11
52wk High:1.80
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.27
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:6.56
PE(LYR):-0.95

Loading ...

BioCardia CEO Peter Altman acquires 5,100 shares for $5,202

Reuters
·
May 16

BioCardia Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

BioCardia Q1 EPS $(0.21) Misses $(0.17) Estimate

Benzinga Earnings
·
May 15

BioCardia, Inc. Q1 Net Income USD -2.259 Million

Reuters
·
May 15

BioCardia Q1 net loss narrows as expenses decline

Reuters
·
May 15

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Operating Income USD -2.266 Million

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Basic EPS USD -0.21

THOMSON REUTERS
·
May 15

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 14

BioCardia schedules first-quarter earnings conference call, corporate update

Reuters
·
May 12

BioCardia provides update on Helix pre-submission meeting with FDA

TIPRANKS
·
May 09

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 08

BioCardia Inc - FDA Prefers Helix Approval Simultaneous With Cardiamp Cell Therapy System Approval

THOMSON REUTERS
·
May 08

BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Agrees on Two Pathways for Helix Marketing Clearance, No Safety Concerns Raised

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Suggests Follow-on Pre-Submission Could Enable Helix Approval via Denovo Pathway

THOMSON REUTERS
·
May 08

BioCardia CEO Peter Altman acquires 5,000 common shares for $5,550

Reuters
·
Apr 30

BioCardia Gains Japanese Patent for Heart3D Imaging Technology

TIPRANKS
·
Apr 28

BioCardia says Japan allows patent for Heart3D fusion imaging software

Reuters
·
Apr 28

BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3d™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During Cardiamp Cell Therapy Procedures

THOMSON REUTERS
·
Apr 28